{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:00:04Z","timestamp":1787068804810,"version":"build-2736575974"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T00:00:00Z","timestamp":1595548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"DOI":"10.3389\/fmolb.2020.00173","type":"journal-article","created":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T08:17:10Z","timestamp":1595578630000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["lncRNA MEG3 Suppresses the Progression of Ankylosis Spondylitis by Regulating the Let-7i\/SOST Axis"],"prefix":"10.3389","volume":"7","author":[{"given":"Junjie","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.berh.2018.09.005","article-title":"Genetics in ankylosing spondylitis - Current state of the art and translation into clinical outcomes.","volume":"31","author":"Brown","year":"2017","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"581","DOI":"10.26355\/eurrev_202001_20034","article-title":"LncRNA MEG3 inhibits proliferation and promotes apoptosis of osteosarcoma cells through regulating Notch signaling pathway.","volume":"24","author":"Chen","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1089\/dna.2017.3805","article-title":"Long noncoding RNA HOXA11-AS functions as miRNA sponge to promote the glioma tumorigenesis through targeting miR-140-5p.","volume":"36","author":"Cui","year":"2017","journal-title":"DNA Cell Biol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3899\/jrheum.170630","article-title":"Opioid analgesic use in patients with ankylosing spondylitis: an analysis of the prospective study of outcomes in an ankylosing spondylitis cohort.","volume":"45","author":"Dau","year":"2018","journal-title":"J. Rheumatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"5397","DOI":"10.3892\/mmr.2019.10210","article-title":"Long noncoding RNA NORAD promotes cell proliferation and glycolysis in nonsmall cell lung cancer by acting as a sponge for miR1365p.","volume":"19","author":"Gao","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"B6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.rdc.2017.04.006","article-title":"Genetics and the causes of ankylosing spondylitis.","volume":"43","author":"Hanson","year":"2017","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"B7","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.canlet.2017.12.029","article-title":"Statistical analysis of non-coding RNA data.","volume":"417","author":"He","year":"2018","journal-title":"Cancer Lett."},{"key":"B8","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1586\/14737167.2014.957679","article-title":"Health-related quality of life in patients with ankylosing spondylitis: a comprehensive review.","volume":"14","author":"Kotsis","year":"2014","journal-title":"Expert Rev. Pharmacoecon. Outcomes Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"389","DOI":"10.5582\/bst.2018.01117","article-title":"Downregulation of lncRNA TUG1 is involved in ankylosing spondylitis and is related to disease activity and course of treatment.","volume":"12","author":"Lan","year":"2018","journal-title":"Biosci. Trends"},{"key":"B10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11010-019-03681-x","article-title":"LncRNA MEG3 inhibits the inflammatory response of ankylosing spondylitis by targeting miR-146a.","volume":"466","author":"Li","year":"2020","journal-title":"Mol. Cell. Biochem."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003325","article-title":"The role of MicroRNAS in ankylosing spondylitis.","volume":"95","author":"Li","year":"2016","journal-title":"Medicine"},{"key":"B12","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3892\/etm.2018.6921","article-title":"lncRNA MEG3 is downregulated in ankylosing spondylitis and associated with disease activity, hospitalization time and disease duration.","volume":"17","author":"Liu","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"15429","DOI":"10.1002\/jcb.28810","article-title":"microRNA-96 promotes osteoblast differentiation and bone formation in ankylosing spondylitis mice through activating the Wnt signaling pathway by binding to SOST.","volume":"120","author":"Ma","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"B14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.55563\/clinexprheumatol\/2l5emt","article-title":"MiR-451 suppresses inflammatory responses in ankylosing spondylitis by targeting macrophage migration inhibitory factor.","volume":"38","author":"Park","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9101964","article-title":"Serum sclerostin as a possible biomarker in ankylosing spondylitis: a case-control study.","volume":"2018","author":"Perrotta","year":"2018","journal-title":"J. Immunol. Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.omtn.2019.10.003","article-title":"miR-17-5p regulates heterotopic ossification by targeting ANKH in ankylosing spondylitis.","volume":"18","author":"Qin","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B17","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nrrheum.2017.56","article-title":"Pathogenesis of ankylosing spondylitis - recent advances and future directions.","volume":"13","author":"Ranganathan","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1007\/s10067-019-04509-1","article-title":"Plasma let-7i, miR-16, and miR-221 levels as candidate biomarkers for the assessment of ankylosing spondylitis in Mexican patients naive to anti-TNF therapy.","volume":"38","author":"Reyes-Loyola","year":"2019","journal-title":"Clin. Rheumatol."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1186\/ar4055","article-title":"Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?","volume":"14","author":"Saad","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-014-0489-6","article-title":"Update on ankylosing spondylitis: current concepts in pathogenesis.","volume":"15","author":"Smith","year":"2015","journal-title":"Curr. Allergy Asthma Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1002\/acr.22869","article-title":"Continuous improvement of physical functioning in ankylosing spondylitis patients by tumor necrosis factor inhibitors: three-year followup and predictors.","volume":"68","author":"van Weely","year":"2016","journal-title":"Arthritis Care Res."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02668","article-title":"The early phases of ankylosing spondylitis: emerging insights from clinical and basic science.","volume":"9","author":"Watad","year":"2018","journal-title":"Front. Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.bone.2016.11.024","article-title":"Sclerostin expression and functions beyond the osteocyte.","volume":"96","author":"Weivoda","year":"2017","journal-title":"Bone"},{"key":"B24","doi-asserted-by":"publisher","first-page":"6267","DOI":"10.1093\/emboj\/cdg599","article-title":"Osteocyte control of bone formation via sclerostin, a novel BMP antagonist.","volume":"22","author":"Winkler","year":"2003","journal-title":"EMBO J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.3892\/ijmm.2018.4038","article-title":"Identification of the key genes and long noncoding RNAs in ankylosing spondylitis using RNA sequencing.","volume":"43","author":"Xu","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/14397595.2018.1453277","article-title":"Predisposition of six well-characterized microRNAs to syndesmophytes among Chinese patients with ankylosing spondylitis.","volume":"29","author":"Yang","year":"2019","journal-title":"Mod. Rheumatol."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-019-2647-4","article-title":"LINC00311 is overexpressed in ankylosing spondylitis and predict treatment outcomes and recurrence.","volume":"20","author":"Zhong","year":"2019","journal-title":"BMC Musculoskelet. Disord."}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmolb.2020.00173\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T05:35:29Z","timestamp":1667540129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmolb.2020.00173\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,24]]},"references-count":27,"alternative-id":["10.3389\/fmolb.2020.00173"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2020.00173","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,24]]},"article-number":"173"}}